Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum
« Previous
123456789101112
Next »

Ben Venue Resumes Limited Production

Oct 23, 2012
By: Patricia Van Arnum

Ben Venue Laboratories has resumed production on a limited number of manufacturing lines in the company's Bedford, Ohio, facilities.

CPhI 2012: Live Report

Oct 10, 2012
By: Patricia Van Arnum

The PTE team is currently in Madrid attending numerous meetings and presentations at CPhI and its collocated events. Read the thoughts of our editor on the highlights of the show so far.

Strategies for Effective Biologics Outsourcing Examined at CPhI

Oct 9, 2012
By: Patricia Van Arnum

Over the years, CPhI has expanded to cover several areas connected with pharmaceutical manufacturing, but one of the prime focuses of the show is still on ingredients, fine chemicals and intermediates. PharmTech Europe’s exceutive editor, Patricia Van Arnum, tells us more.

Pharmaceutical Companies Partner in Global Health

A recent review evaluates the nature of global health partnerships and critical factors for their success.
Oct 3, 2012
By: Patricia Van Arnum

A recent review evaluates the nature of global health partnerships and critical factors for their success.

Fine-Chemical Producers and Contract Manufacturers Meet at CPhI

Fine-chemical manufacturers producers and contract manufacturers roll out manufacturing and service expansions at CPhI in Madrid.
Oct 3, 2012
By: Patricia Van Arnum

Fine-chemical manufacturers producers and contract manufacturers roll out manufacturing and service expansions at CPhI in Madrid.

Pharma Majors Build Manufacturing Capacity in Russia

Several Big Pharma companies strengthen their manufacturing presence in Russia.
Oct 3, 2012
By: Patricia Van Arnum

Several Big Pharma companies strengthen their manufacturing presence in Russia.

Merck Serono Launches New Spin-off Company; Provides Update on Restructuring

Oct 3, 2012
By: Patricia Van Arnum

Merck Serono's Asceneuron is the third company to be spun off from the company's Entrepreneur Partnership Program that was launched to mitigate the impact from recent restructuring at its Geneva site.

Advancing Protein Crystallization: Microgravity Effects and Predictive Models

Recent research on elucidating the structure and sequence of proteins involves examining the effect of microgravity on protein crystallization and a computational model for protein elucidation.
Oct 2, 2012
By: Patricia Van Arnum

Recent research on elucidating the structure and sequence of proteins involves examining the effect of microgravity on protein crystallization and a computational model for protein elucidation.

Combination Drugs: Adding Up the Opportunities

Fixed-dose combination drug therapies give rise to innovation in solid-dosage formulations and manufacturing.
Oct 2, 2012
By: Patricia Van Arnum

Fixed-dose combination drug therapies give rise to innovation in solid-dosage formulations and manufacturing.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
43%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
14%
Raw material supply problems
14%
Regulatory restrictions
0%
Business decisions to limit production
29%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here